Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Grazax for asthma prevention in children with grass pollen allergy
NCT01061203Phase 3Completed
- Sponsor
- ALK-Abelló
- Start
- Jan 2010
- Primary completion
- Sep 2015
- Modality
- Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of grass-pollen extract in asthma, sponsored by ALK-Abelló. Started Jan 2010; status: completed.
02
Drugs
grass-pollen extract
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01061203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01061203.